Cargando…

Identification of key pathways and genes in nonalcoholic fatty liver disease using bioinformatics analysis

INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is one of the most common types of liver disease in the world. However, the molecular mechanisms regulating the development of NAFLD have remained unclear. MATERIAL AND METHODS: In the present study, we analyzed two public datasets (GSE48452 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingqi, Lin, Bogeng, Chen, Zhiqing, Deng, Manxiang, Wang, Ye, Wang, Jisu, Chen, Luling, Zhang, Zhenyu, Xiao, Xueling, Chen, Chunlin, Song, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069441/
https://www.ncbi.nlm.nih.gov/pubmed/32190149
http://dx.doi.org/10.5114/aoms.2020.93343
Descripción
Sumario:INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is one of the most common types of liver disease in the world. However, the molecular mechanisms regulating the development of NAFLD have remained unclear. MATERIAL AND METHODS: In the present study, we analyzed two public datasets (GSE48452 and GSE89632) to identify differentially expressed mRNAs in the progression of NAFLD. Next, we performed bioinformatics analysis to explore key pathways underlying NAFLD development. RESULTS: Gene Ontology (GO) analysis showed that differentially expressed genes (DEGs) were mainly involved in regulating a series of metabolism-related pathways (including proteolysis and lipid metabolism), cell proliferation and adhesion, the inflammatory response, and the immune response. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that DEGs in NAFLD were mainly enriched in the insulin signaling pathway, peroxisome proliferator-activated receptor (PPAR) signaling pathway, and p53 signaling pathway. We also constructed protein-protein interaction (PPI) networks for these DEGs. Interestingly, we observed that key hub nodes in PPI networks were also associated with the progression of hepatocellular carcinoma (HCC). CONCLUSIONS: Taken together, our analysis revealed that a series of pathways, such as metabolism and PPAR signaling pathways, were involved in NAFLD development. Moreover, we observed that many DEGs in NAFLD were also dysregulated in HCC. Although further validation is still needed, we believe this study could provide useful information to explore the potential candidate biomarkers for diagnosis, prognosis, and drug targets of NAFLD.